A successful technocrat of global standing, Ms. Shaw heads India’s leading Biotechnology enterprise, Biocon. She is highly respected in the corporate world and her pioneering efforts in biotechnology have drawn global recognition both for Indian Industry and Biocon. Fierce Biotech, the biotech industry’s daily monitor, placed Ms. Shaw among the 25 most influential people in the Biopharma Business for 2012.
Ms. Shaw is a part of the U.S. Pharmacopeial Convention (USP) Board of Trustees and is also a Member of the USP Biologics Advisory Group. She has served on the Board of Science Foundation, Ireland. Ms. Shaw is the founder member of the Karnataka’s Vision Group on Biotechnology and currently chairs this forum. She also serves on the National Advisory Council of the Government’s Department of Biotechnology, where she has been instrumental in bringing government, industry and academia together, to charter a clear and progressive growth path for Biotechnology in India. Ms. Shaw serves as Member, Governing Body and General Body of the Indian Pharmacopoeia Commission, an Autonomous Body of the Government of India.
Ms. Shaw received a graduate honors degree in Zoology from Bangalore University (1973) and qualified as a Master Brewer from Ballarat University, Australia (1975). Ms Shaw also received an honorary Doctorate of Science in 2004, from her alma mater, Ballarat University, in recognition of her pre-eminent contributions to the field of Biotechnology. She has also been awarded honorary doctorates from University of Abertay, Dundee, U.K. (2007), University of Glasgow, U.K. (2008) and Heriot-Watt University, Edinburgh, U.K. (2008). She has also received an honorary Doctorate of Science from the National University of Ireland (2012) for her contribution to economic life and was also conferred an honorary doctorate by Trinity College, Dublin (2012).
Her most cherished awards are the national awards, PADMA SHRI (1989) and PADMA BHUSHAN (2005) presented to her by the President of India, for her pioneering efforts in Industrial Biotechnology.
Under her stewardship, Biocon has evolved from its inception in 1978 as an industrial enzymes company to a fully integrated Biopharmaceutical enterprise encompassing a well-balanced business portfolio of products and services with a research focus on Diabetes, Oncology and Auto-immune disease. Biocon also has a subsidiary, Syngene, which was established in 1994 to provide research services and contract manufacturing to the big pharma industry.
She is also the Honorary Consul of Ireland in Bangalore.
